We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

354 hedge funds and large institutions have $6.43B invested in Bio-Rad Laboratories Class A in 2019 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 148 increasing their positions, 97 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 29

53% more repeat investments, than reductions

Existing positions increased: 148 | Existing positions reduced: 97

10% more capital invested

Capital invested by funds: $5.87B → $6.43B (+$562M)

7% more funds holding

Funds holding: 330 → 354 (+24)

2.26% more ownership

Funds ownership: 75.91% → 78.17% (+2.3%)

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

69% less call options, than puts

Call options by funds: $9.75M | Put options by funds: $31.4M

Holders
354
Holders Change
+24
Holders Change %
+7.27%
% of All Funds
7.76%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.15%
New
54
Increased
148
Reduced
97
Closed
29
Calls
$9.75M
Puts
$31.4M
Net Calls
-$21.7M
Net Calls Change
-$37.2M

Top Buyers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$121M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$96.4M
3
BlackRock
BlackRock
New York
+$48.4M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$37M
5
Citadel Advisors
Citadel Advisors
Florida
+$34.7M

Top Sellers

1
EIP
Easterly Investment Partners
Massachusetts
-$120M
2
Russell Investments Group
Russell Investments Group
United Kingdom
-$61.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$47.9M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$28.5M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$26.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$698M +$48.4M +148,312 +8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$640M +$6.5M +19,938 +1%
ACM
3
Atlanta Capital Management
Georgia
$251M -$764K -2,343 -0.3%
American Century Companies
4
American Century Companies
Missouri
$242M -$6.94M -21,260 -3%
Wells Fargo
5
Wells Fargo
California
$223M +$22.8M +69,761 +12%
State Street
6
State Street
Massachusetts
$167M +$2.28M +7,000 +1%
Fidelity Investments
7
Fidelity Investments
Massachusetts
$164M +$96.4M +295,391 +149%
Millennium Management
8
Millennium Management
New York
$157M -$17.8M -54,563 -10%
UBS AM
9
UBS AM
Illinois
$139M +$6.94M +21,281 +5%
Westfield Capital Management
10
Westfield Capital Management
Massachusetts
$137M +$17.1M +52,300 +15%
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
$123M +$121M +370,554 New
AllianceBernstein
12
AllianceBernstein
Tennessee
$123M +$1.46M +4,469 +1%
Bank of America
13
Bank of America
North Carolina
$109M +$3.36M +10,300 +3%
EIP
14
Easterly Investment Partners
Massachusetts
$90.9M -$120M -368,654 -57%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$86.4M -$2.72M -8,333 -3%
Fisher Asset Management
16
Fisher Asset Management
Washington
$83.6M +$3.74M +11,462 +5%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$76.7M +$4.78M +14,664 +7%
Russell Investments Group
18
Russell Investments Group
United Kingdom
$74.6M -$61.1M -187,188 -46%
AI
19
Ariel Investments
Illinois
$74.6M -$2.33M -7,146 -3%
Invesco
20
Invesco
Georgia
$74.4M +$12.2M +37,484 +20%
PC
21
Polar Capital
United Kingdom
$70.5M -$9.98M -30,579 -13%
Norges Bank
22
Norges Bank
Norway
$69.7M +$508K +1,558 +0.7%
Northern Trust
23
Northern Trust
Illinois
$64.8M +$1.37M +4,186 +2%
IIP
24
Intermede Investment Partners
United Kingdom
$64.8M +$17.5M +53,569 +38%
THP
25
Tower House Partners
United Kingdom
$63.2M -$3.26M -10,000 -5%
1
2 3 4 5

BIO Hedge Fund Activity: Q3 2019 in Review

354 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2019, worth a combined $6.43B — up 9.6% from $5.87B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new BIO positions and 29 closed out — a net gain of 25 holders — while 148 added to existing stakes and 97 trimmed.

The largest buyer was Acadian Asset Management, opening a new position worth an estimated $121M. The largest seller was Easterly Investment Partners, cutting an estimated $120M.

  • 354 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2019, up from 330 in Q2 2019.
  • Funds reported $6.43B of Bio-Rad Laboratories Class A stock for Q3 2019, up 9.6% quarter-over-quarter.
  • 54 funds opened new Bio-Rad Laboratories Class A positions in Q3 2019 and 29 closed out, a net change of +25 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2019 was Acadian Asset Management, an estimated $121M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2019 was Easterly Investment Partners, an estimated $120M sold.

Based on aggregated 13F filings for Q3 2019.